Press Releases

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd.

This new partnership will see the distribution of The Company’s standardized, naturally derived, psilocybin containing mushrooms to local Jamaican dispensaries for legal sale Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural […]

HAVN Life Signs Supply Agreement with Licenced Jamaican Cannabis Producer, Green Stripe Naturals Ltd. Read More »

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil

Through the Partnership, the Company will seek Health Canada approval to supply naturally-derived psilocybin for legal and therapeutic use via the Special Access Program Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of

HAVN Life Announces Strategic Partnership with Non-Profit Coalition, TheraPsil Read More »

HAVN Life Secures Supply Agreement with Atman Retreats

This new partnership will see the distribution of the Company’s standardized, naturally derived, psilocybin containing mushrooms for therapeutic use at Atman retreats in Jamaica Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of

HAVN Life Secures Supply Agreement with Atman Retreats Read More »

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia Read More »

HAVN Life Launches the Brain Evolve Series

The four formulations, helping to reduce inflammation, promote restorative sleep and support cognitive function are now available on yourhavnlife.com Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is

HAVN Life Launches the Brain Evolve Series Read More »

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.

The expanded partnership to include the distribution of functional mushrooms, HAVN Life natural health products and white label products, in addition to its naturally-derived psilocybin compounds Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc. Read More »

HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc.

With this deal, The Company’s full line of natural health formulations will now be available across Canada at select health food store locations Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural

HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc. Read More »

HAVN Life Closes C$2,000,000 Private Placement with U.S. Institutional Investors

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is pleased to announce that it has closed its previously announced sale of units to U.S. institutional investors, for gross

HAVN Life Closes C$2,000,000 Private Placement with U.S. Institutional Investors Read More »

HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op

The Company’s full line of natural health formulations will be available at select locations starting in May Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce

HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op Read More »

HAVN Life To Present at Upcoming Emerging Growth Conference 26

CEO Tim Moore will share recent partnership and distribution news and a roadmap for the Company’s plans for the next quarter Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support

HAVN Life To Present at Upcoming Emerging Growth Conference 26 Read More »

Scroll to Top